Advertisement
Revolution Medicines, Inc.

Revolution Medicines, Inc. (RVMD) Stock Overview

Explore Revolution Medicines, Inc.’s financial performance, market position, analyst ratings, and future outlook.

RVMD●NASDAQ
HealthcareBiotechnology
$155.69
$0.30(0.19%)
U.S. Market opens in 16h 7m
Advertisement

Revolution Medicines, Inc. (RVMD)

Meyka AI Score

Z

Key Financials

Market Cap33.1B
P/E Ratio-22.50
EPS (TTM)$-7.11
ROE-0.83%
Fundamental Analysis

AI Price Forecasts

1 Month$104.05
3 Months$140.06
1 Year Target$92.17

RVMD Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Revolution Medicines, Inc. (RVMD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 58.24, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $92.17.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -22.50 and a market capitalization of 33.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.30%
5-Day Change
-0.09%
1-Month Change
5.15%
3-Month Change
53.69%
6-Month Change
98.17%
Year-to-Date (YTD) Change
95.25%
1-Year Change
285.14%
3-Year Change
502.32%
5-Year Change
410.07%
All-Time (Max) Change
438.13%

Contact Information

https://www.revmed.com
650 481 6801
700 Saginaw Drive, Redwood City, CA, 94063

Company Facts

616 Employees
IPO DateFeb 13, 2020
CountryUS
Actively Trading

Frequently Asked Questions